Melfen (Ibuprofen)

Ibuprofen works by reversibly blocking the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which are essential for converting arachidonic acid into prostaglandins. By lowering prostaglandin levels, it reduces peripheral pain signaling, lowers the hypothalamic set‑point for temperature, and diminishes inflammation in affected tissues.

The dosage of Melfen is determined by the prescribing healthcare professional based on the patient’s age, weight, clinical condition, and response to therapy. The prescriber will select the appropriate strength, frequency, and duration in accordance with current clinical guidelines and regulatory labeling.

Ibuprofen is generally avoided during the third trimester of pregnancy because it may affect fetal cardiovascular development. Use in earlier trimesters should be under medical supervision. While small amounts pass into breast milk, it is usually considered compatible with breastfeeding if the benefit outweighs potential risk; a healthcare provider should evaluate each case.

To order Melfen, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the team provides pricing, availability, shipping details (including any cold‑chain requirements if applicable), and assists with import documentation.

Melfen (ibuprofen) shares the core anti‑inflammatory and analgesic properties of the NSAID class but differs in potency, half‑life, and safety profile. Compared with aspirin, ibuprofen has a lower risk of gastric irritation at standard doses. Relative to naproxen, ibuprofen’s shorter half‑life may require more frequent dosing but offers quicker onset of pain relief. Choice of NSAID should consider individual patient risk factors and therapeutic goals.

Melfen should be stored at room temperature, preferably below 25 °C, in its original packaging to protect it from moisture and direct sunlight. Keep the container tightly closed and out of reach of children. Do not store in bathrooms or near heat sources, and discard any product that shows signs of degradation such as discoloration or unusual odor.

Melfen is taken orally with a full glass of water. It may be taken with or without food; however, taking it with meals can reduce the likelihood of gastrointestinal discomfort. Swallow tablets or capsules whole; do not crush or chew unless the formulation specifically allows it. Follow the prescriber’s instructions regarding timing and frequency.

The most serious risks include gastrointestinal bleeding or ulceration, acute kidney injury, and increased cardiovascular events such as heart attack or stroke, especially with high‑dose or prolonged use. Rare but severe reactions can involve severe skin disorders (e.g., Stevens‑Johnson syndrome) and anaphylaxis. Patients should seek immediate medical attention if they experience signs of serious bleeding, severe rash, or breathing difficulties.

Melfen should be avoided in individuals with known hypersensitivity to ibuprofen or other NSAIDs, active gastrointestinal ulceration or bleeding, severe heart failure, or advanced renal impairment. It is also contraindicated in the third trimester of pregnancy. Patients on anticoagulant therapy, certain antihypertensives, or those with a history of cardiovascular disease should consult a healthcare professional before use.